4,000 Shares in Colgate-Palmolive (NYSE:CL) Bought by Enhancing Capital LLC

Enhancing Capital LLC bought a new position in shares of Colgate-Palmolive (NYSE:CL) during the 4th quarter, HoldingsChannel.com reports. The fund bought 4,000 shares of the company’s stock, valued at approximately $364,000.

Several other institutional investors have also recently bought and sold shares of CL. Kohmann Bosshard Financial Services LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $26,000. Centricity Wealth Management LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $27,000. Union Bancaire Privee UBP SA acquired a new position in Colgate-Palmolive during the fourth quarter worth $32,000. Briaud Financial Planning Inc acquired a new position in Colgate-Palmolive during the fourth quarter worth $32,000. Finally, Wintrust Investments LLC acquired a new position in Colgate-Palmolive during the fourth quarter worth $33,000. Institutional investors and hedge funds own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $89.45 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $72.59 billion, a PE ratio of 25.41, a P/E/G ratio of 4.20 and a beta of 0.40. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The company has a 50-day moving average price of $89.13 and a two-hundred day moving average price of $94.44.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the firm earned $0.87 earnings per share. Equities analysts forecast that Colgate-Palmolive will post 3.75 EPS for the current year.

Wall Street Analysts Forecast Growth

CL has been the subject of several analyst reports. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a report on Tuesday, January 7th. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $97.00 to $99.00 and gave the company an “overweight” rating in a report on Friday, March 14th. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a report on Monday, February 3rd. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. Finally, TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.